We are live on ! Find out more
NSPR icon

InspireMD
NSPR

28 hedge funds and large institutions have $24M invested in InspireMD in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less funds holding

Funds holding: 29 → 28 (-1)

4.89% less ownership

Funds ownership: 48.27% → 43.39% (-4.9%)

18% less capital invested

Capital invested by funds: $29.2M → $24M (-$5.27M)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
28
Holders Change
-1
Holders Change %
-3.45%
% of All Funds
0.4%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
2
Increased
2
Reduced
4
Closed
3
Calls
$47K
Puts
–
Net Calls
+$47K
Net Calls Change
+$47K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$198K
2
JC
Jetstream Capital
Tennessee
+$94.4K
3
NA
Nottingham Advisors
New York
+$13.5K
4
Simplex Trading
Simplex Trading
Illinois
+$297

Top Sellers

Rank Fund Capital Flow
1
RA
Rosalind Advisors
Ontario, Canada
-$645K
2
Morgan Stanley
Morgan Stanley
New York
-$171K
3
HighTower Advisors
HighTower Advisors
Illinois
-$76K
4
Northern Trust
Northern Trust
Illinois
-$8.76K
5
Renaissance Technologies
Renaissance Technologies
New York
-$7.01K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$5.06M – – –
NCM
2
Nantahala Capital Management
Connecticut
$4.9M – – –
Marshall Wace
3
Marshall Wace
United Kingdom
$4.28M – – –
SCM
4
Soleus Capital Management
Connecticut
$3.27M – – –
VCIM
5
Velan Capital Investment Management
Georgia
$2.14M – – –
RA
6
Rosalind Advisors
Ontario, Canada
$1.63M -$645K -239,132 -26%
PVI
7
Pura Vida Investments
New York
$1.07M – – –
Millennium Management
8
Millennium Management
New York
$970K +$198K +73,355 +21%
Morgan Stanley
9
Morgan Stanley
New York
$151K -$171K -63,530 -50%
JC
10
Jetstream Capital
Tennessee
$83K +$94.4K +35,000 New
MFIM
11
Mesirow Financial Investment Management
Illinois
$71.1K – – –
NA
12
Nottingham Advisors
New York
$71.1K +$13.5K +5,000 +20%
Northern Trust
13
Northern Trust
Illinois
$59.7K -$8.76K -3,248 -11%
AC
14
Avestar Capital
New York
$47.4K – – –
HCM
15
Hollencrest Capital Management
California
$47.4K – – –
Geode Capital Management
16
Geode Capital Management
Massachusetts
$42K – – –
Renaissance Technologies
17
Renaissance Technologies
New York
$29K -$7.01K -2,600 -17%
MCWS
18
McKinley Carter Wealth Services
West Virginia
$23.7K – – –
AF
19
Advisornet Financial
Minnesota
$20.8K – – –
Osaic Holdings
20
Osaic Holdings
Arizona
$7.11K – – –
BAM
21
Bellevue Asset Management
Washington
$4.08K – – –
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$3K – – –
National Bank of Canada
23
National Bank of Canada
Quebec, Canada
$453 – – –
Group One Trading
24
Group One Trading
Illinois
$251 – – –
GRP
25
Global Retirement Partners
California
$64 – – –
1
2

NSPR Hedge Fund Activity: Q1 2024 in Review

28 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q1 2024, worth a combined $24M — down 18% from $29.2M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of NSPR and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 2 added.

The largest buyer was Millennium Management, adding an estimated $198K. The largest seller was Rosalind Advisors, cutting an estimated $645K.

  • 28 institutional investors held InspireMD (NSPR) as of Q1 2024, down from 29 in Q4 2023.
  • Funds reported $24M of InspireMD stock for Q1 2024, down 18% quarter-over-quarter.
  • 2 funds opened new InspireMD positions in Q1 2024 and 3 closed out, a net change of -1 holder.
  • The largest InspireMD buyer in Q1 2024 was Millennium Management, an estimated $198K added.
  • The largest InspireMD seller in Q1 2024 was Rosalind Advisors, an estimated $645K sold.

Based on aggregated 13F filings for Q1 2024.